RNTX
Rein Therapeutics
RNTX
RNTX
17 hedge funds and large institutions have $1.83M invested in Rein Therapeutics in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
11% less funds holding
Funds holding: 19 → 17 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
17
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.65K | |
| 2 | +$2.25K | |
| 3 | +$768 | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$442 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| 1 | -$33.3K | |
| 2 | -$14K | |
| 3 | -$4.57K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$266 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$27 |